Bullish Case: DXCM at $85.36 shows call volume 40% above puts and bullish risk exceeding bearish risk by 15% across tenors. Helium's price density peaks near $86-87, and the 01/21/2028 125C (delta 0.34) was the day's highest-volume contract, signaling institutional upside positioning. CGM adoption evidence (BMJ feasibility data) supports secular growth. Market IV (~40-43%) vs. Helium's lower term-structure estimate leaves premium rich for defined-risk bullish-vol structures.

Bearish Case: Helium's AI point forecast is -0.91% with a -0.1 realized correlation, and DXCM has drifted -4.8% in a month despite prior rally calls being undercalled. Market density at 15% probability puts weight on $85-87, but the $90-100 upper region carries only thin probability while put skew ($80-85 strikes, IV 40-46%) prices persistent downside. A payer/regulatory shock or Q3 guidance disappointment would exploit the 20.8 P/B valuation into the $75-80 zone.

Potential Outcomes:

1. Flat $82-$88 (50%): Helium/market densities both peak at $85-87; falsified by a close outside the band by early November.
2. Mild rally $88-$95 (25%): call-heavy flow + 15% bullish risk skew; falsified without sustained closes >$88.
3. Mild drop $78-$82 (15%): Helium point forecast negative; falsified if $85 holds through earnings window.
4. Selloff <$78 (7%): IV >30% spike on payer/competition catalyst; falsified absent event.
5. Breakout >$100 (3%): requires M&A or guidance surprise.

Oracle: while near-dated IV (~33-47%) stays above Helium's curve (7-22%), defined-risk put-credit structures align with the flat-regime; a >30% IV jump flips to long-put hedges.

October 03, 2026